Genome-wide characterization of SARS-CoV-2 cytopathogenic proteins in the search of antiviral targets.
Cruz Cosme, Ruth S
Simard, J Marc
Zhao, Richard Y
JournalbioRxiv : the Preprint Server for Biology
PublisherCold Spring Harbor Laboratory
MetadataShow full item record
AbstractTherapeutic inhibition of critical viral functions is important for curtailing coronavirus disease-2019 (COVID-19). We sought to identify antiviral targets through genome-wide characterization of SARS-CoV-2 proteins that are crucial for viral pathogenesis and that cause harmful cytopathic effects. All twenty-nine viral proteins were tested in a fission yeast cell-based system using inducible gene expression. Twelve proteins including eight non-structural proteins (NSP1, NSP3, NSP4, NSP5, NSP6, NSP13, NSP14 and NSP15) and four accessory proteins (ORF3a, ORF6, ORF7a and ORF7b) were identified that altered cellular proliferation and integrity, and induced cell death. Cell death correlated with the activation of cellular oxidative stress. Of the twelve proteins, ORF3a was chosen for further study in mammalian cells. In human pulmonary and kidney epithelial cells, ORF3a induced cellular oxidative stress associated with apoptosis and necrosis, and caused activation of pro-inflammatory response with production of the cytokines TNF-α, IL-6, and IFN-β1, possibly through the activation of NF-κB. To further characterize the mechanism, we tested a natural ORF3a Beta variant, Q57H, and a mutant with deletion of the highly conserved residue, ΔG188. Compared to wild type ORF3a, the ΔG188 variant yielded more robust activation of cellular oxidative stress, cell death, and innate immune response. Since cellular oxidative stress and inflammation contribute to cell death and tissue damage linked to the severity of COVID-19, our findings suggest that ORF3a is a promising, novel therapeutic target against COVID-19.
apoptosis and necrosis
cellular pro-inflammatory response
viral therapeutic target
Identifier to cite or link to this itemhttp://hdl.handle.net/10713/17569
- Genome-Wide Characterization of SARS-CoV-2 Cytopathogenic Proteins in the Search of Antiviral Targets.
- Authors: Zhang J, Li Q, Cruz Cosme RS, Gerzanich V, Tang Q, Simard JM, Zhao RY
- Issue date: 2022 Feb 15
- Manipulation of autophagy by SARS-CoV-2 proteins.
- Authors: Koepke L, Hirschenberger M, Hayn M, Kirchhoff F, Sparrer KM
- Issue date: 2021 Sep
- The importance of accessory protein variants in the pathogenicity of SARS-CoV-2.
- Authors: Hassan SS, Choudhury PP, Dayhoff GW 2nd, Aljabali AAA, Uhal BD, Lundstrom K, Rezaei N, Pizzol D, Adadi P, Lal A, Soares A, Mohamed Abd El-Aziz T, Brufsky AM, Azad GK, Sherchan SP, Baetas-da-Cruz W, Takayama K, Serrano-Aroca Ã, Chauhan G, Palu G, Mishra YK, Barh D, Santana Silva RJ, Andrade BS, Azevedo V, Góes-Neto A, Bazan NG, Redwan EM, Tambuwala M, Uversky VN
- Issue date: 2022 Mar 15
- Understanding the Role of SARS-CoV-2 ORF3a in Viral Pathogenesis and COVID-19.
- Authors: Zhang J, Ejikemeuwa A, Gerzanich V, Nasr M, Tang Q, Simard JM, Zhao RY
- Issue date: 2022
- SARS-CoV-2 suppresses IFNβ production mediated by NSP1, 5, 6, 15, ORF6 and ORF7b but does not suppress the effects of added interferon.
- Authors: Shemesh M, Aktepe TE, Deerain JM, McAuley JL, Audsley MD, David CT, Purcell DFJ, Urin V, Hartmann R, Moseley GW, Mackenzie JM, Schreiber G, Harari D
- Issue date: 2021 Aug